Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis

Journal of Periodontology

Volumn 69, Issue 12, 1998, Pages 1419-1425

  Graves, Dana T ^a,c   Delima, A J ^a   Assuma, R ^a   Amar, S ^a   Oates, T ^b   Cochran, D ^b  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alveolar bone loss; Animal studies; Cell movement; Interleukin 1; Periodontal diseases complications; Tooth loss; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ARTICLE; CELL MOTION; DISEASE COURSE; DISEASE MODEL; DRUG ANTAGONISM; EPITHELIUM; GINGIVITIS; HUMAN; JAW; MACACA; MICROBIOLOGY; MONONUCLEAR CELL; NEUTROPHIL; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTITIS; PHYSIOLOGY; PORPHYROMONAS GINGIVALIS;

ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; ANIMALS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIUM; GINGIVITIS; HUMANS; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; MACACA FASCICULARIS; NEUTROPHILS; OSTEOCLASTS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; TOOTH LOSS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032249743     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1998.69.12.1419     Document Type: Article

References (42)

1. Williams R. Periodontal disease. New Engl J Med 1990;322:373-382.
2. Genco R. Host responses in periodontal diseases: current concepts. J Periodontol 1992;63(Suppl.):338-355.
3. Page R. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 1991;26:230-242.
4. Listgarten M. Pathogenesis of periodontitis. J Clin Periodontol 1986;13:418-430.
5. Armitage GC. Periodontal diseases: Diagnosis. Ann Periodontol 1996;1:37-215.
6. 2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986;21:101-112.
7. Williams R, Jeffcoat M, Kaplan M, Goldhaber P, Johnson H, Wechter W. Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Science 1985;227:640-642.
8. Howell T. Blocking periodontal disease progression with anti-inflammatory agents. J Periodontol 1993;64(Suppl.):828-833.
9. Dinarello C. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-2147.
10. Pfizenmaier K, Wajant H, Grell M. Tumor necrosis factors in 1996. Cytk Growth Factor Rev 1996;7:271-277.
11. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. New Eng J Med 1996;334:1717-1725.
12. Amar S, Van Dyke T, Eugster H, Schultze N, Koebel P, Bluethmann H. TNF-induced cutaneous necrosis is mediated by tumor necrosis factor receptor R1. Inflamm 1997;47:180-186.
13. Ridderstad A,. Abedi-Valugerdi M, Moller E. Cytokines in rheumatoid arthritis. Ann Med 1991;23:219-223.
14. de Waal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries J. Interleukin 10(IL-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10produced by nionocytes. J Exp Med 1991;174:1209-1220.
15. Essner R, Rhoades K, Mcbride W, Morton D, Economou J. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989;142:3857-3861.
16. Arend W, Dayer J. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheumatism 1990;33:305-315.
17. Joosten LA, Helsen MM, van de Loo FA, van den Berg WB. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheumatism 1996;39:797-809.
18. Rosenbaum J, Boney R. Use of soluble interleukin-1 receptor to inhibit ocular inflammation. Current Eye Res 1991;10:1137-1139.
19. Ulich T, Yi E, Yin S, Smith C, Remick D. Intratracheal administration of endotoxin and cytokines. VII. The soluble interlukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation. Clin Immun Immunopathol 1994;72:137-140.
20. Haak-Frendscho M, Marsters S, Mordenti J, et al. Inhibition of TNF by a TNF receptor immunoadhesion. Comparison to anti-TNF monoclonal antibody. J Immunol 1994;152:1347-1353.
21. Moreland L, Baumgartner S, Schiff M, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. New Engl J Med 1997;337:141-147.
22. Madden T, Caton J. Animal models for periodontal disease. Methods Enz 1994;235:106-119.
23. Schou S, Holmstrup P, Kornman KS. Non-human primates used in studies of periodontal disease pathogenesis: a review of the literature. J Periodontol 1993;64:497-508.
24. Maliszewski C, Fanslow W. Soluble receptors for IL-1 and IL-4: biological activity and therapeutic potential. Trends Biotech 1990;8: 324-329.
25. Nagahata T, Kiyoshige T, Tomono S, et al. Oral implantation of Bacteroides asaccharolyticis and Eikenella corrodens in conventional hamsters. Infect Immun 1982;36:304-309.
26. Masada M, Persson R, Kenny J, Lee S, Page R, Allison A. Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J Periodont Res 1990;25:156-163.
27. Honig J, Rordorf-Adam C, Siegmund C, Wiedemann W, Erard F. Increased interleukin-1 beta (IL-1 beta) concentration in gingival tissue from periodontitis patients. J Periodont Res 1989;24:362-367.
28. Jandinski J, Stashenko P, Feder L, et al. Localization of interleukin-1 beta in human periodontal tissue. J Periodontol 1991;62:36-43.
29. Smith M, Braswell L, Coll ins J, et al. Changes in inflammatory mediators in experimental periodontitis in the rhesus monkey. Infect Immun 1993;61:1453-1459.
30. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodont 1997;24:72-77.
31. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJP, Mundy GR. Effects of interleukin-1 on bone turnover in normal mice. Endocrinol 1989;125:1142-1150.
32. Rossomando E, Kennedy JE, Hadjimichael J. Tumor necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Arch Oral Biol 1990;35:431-434.
33. Stashenko P, Dewhirst F, Peros W, Kent R, Ago J. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in hone resorption. J Immunol 1987;138:1464-1468.
34. Graves DT, Jiang Y. Chemokines, a family of chemotactic cytokines. Crit Rev Oral Biol Med 1995;6:109-118.
35. Pemberthy TW, Jiang Y, Graves, DT. Leukocyte adhesion molecules. Crit Rev Oral Biol Med 1997;8:380-388.
36. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloprotemases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
37. Krane S, Conca W, Stephenson M, Amento E, Goldring M. Mechanisms of matrix degradation in rheumatoid arthritis. Ann New York Acad Sci 1990;580:340-354.
38. Thomson BM, Saklatvala EF, Chambers TJ. Osteoblasts mediate interleukin-1 stimulation of bone resorption by rat osteoclast. J Exp Med 1986;164:104-112.
39. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998;160:403-409.
40. Sussman H, Bartels H, Stahl S. The potential of microorganisms to invade the lamina propria of human gingival tissues. J Periodontol 1969;40:210-215.
41. Silverstein L, Schuster G, Garnick J, Singh B. Bacterial penetration of gingiva in the adult beagle dog with periodontitis. J Periodontol 1990;61:35-41.
42. Anderson D, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and pl50.95 glycoproteins. Ann Rev Med 1987;38:175-194.